INVO Fertility Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	7.53	6.84	6.53	3.02
Revenue Growth	13.76%	4.73%	116.25%	-
Cost of Revenue	4.87	4.31	3.66	1.93
Gross Profit	2.66	2.53	2.87	1.09
Selling, General & Admin	8.02	7.69	8.07	7.49
Research & Development	-	-	0	0.17
Operating Expenses	8.59	8.37	8.99	7.85
Operating Income	-5.93	-5.84	-6.12	-6.77
Interest Expense	-1.13	-1.3	-1.04	-0.93
Currency Exchange Gain (Loss)	-	-	-	-0
Other Non Operating Income (Expenses)	0.44	4.23	-	-
EBT Excluding Unusual Items	-6.46	-2.91	-7.15	-7.69
Gain (Loss) on Sale of Investments	0.03	0.03	0.01	-0.15
Gain (Loss) on Sale of Assets	-	-	-0.51	-
Asset Writedown	-	-1.4	-	-
Other Unusual Items	1.05	-1.21	0.05	-0.16
Pretax Income	-5.38	-5.49	-7.6	-8.01
Income Tax Expense	-0.09	-0.15	0.14	0.03
Earnings From Continuing Operations	-5.29	-5.34	-7.74	-8.03
Earnings From Discontinued Operations	-	-17.99	-1.52	-
Net Income	-5.29	-23.32	-9.26	-8.03
Preferred Dividends & Other Adjustments	1.81	1.81	0.25	-
Net Income to Common	-7.09	-25.13	-9.51	-8.03
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	1	0	-	-
Shares Outstanding (Diluted)	1	0	-	-
Shares Change	-	-	-	-
EPS (Basic)	-6.76	-214.64	-	-
EPS (Diluted)	-6.80	-214.64	-	-
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-4.81	-7.06	-3.16	-5.2
Free Cash Flow Per Share	-4.58	-60.28	-	-
Gross Margin	35.28%	36.96%	44.00%	35.96%
Operating Margin	-78.72%	-85.37%	-93.63%	-224.03%
Profit Margin	-94.17%	-367.33%	-145.59%	-266.00%
Free Cash Flow Margin	-63.85%	-103.17%	-48.35%	-172.14%
EBITDA	-5.37	-5.16	-5.2	-6.57
EBITDA Margin	-71.26%	-75.46%	-79.55%	-217.38%
D&A For EBITDA	0.56	0.68	0.92	0.2
EBIT	-5.93	-5.84	-6.12	-6.77
EBIT Margin	-78.72%	-85.37%	-93.63%	-224.03%
Revenue as Reported	7.53	6.84	6.53	3.02

SEC Filings: 10-K · 10-Q